Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Recognify Life Sciences Inc.

United States 6000 Shoreline Court, 94080-7605, United States

About the sponsor

Research activity is centered on schizophrenia, with attention to symptoms affecting cognition, function, and daily living. The sponsor’s clinical interest includes treatment areas linked to cognitive impairment associated with schizophrenia and related neuropsychiatric outcomes.

  • Schizophrenia
  • Cognitive impairment
  • Neuropsychiatric disorders

The portfolio reflects a focus on clinical areas where cognitive performance is a central therapeutic concern.

About Specializations

Recognify Life Sciences Inc. runs clinical trials in conditions such as Cognitive disorder, Schizophrenia, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Cognitive disorder+1

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:(2R,3S)-2-Amino-3-Hydroxy-3-Pyridin-4-Yl-1-Pyrrolidin-1-Ylpropan-1-One (2R,3R)-2,3-Dihydroxybutanedioic Acid
  • Sponsor:Recognify Life Sciences Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.